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granted.Barely a day goes by when I don’t read or hear about the incredible growth anddevelopment in China. The Chinese economy continues to rapidly expand, and weare frequently reminded of the monetary debt of the United States that is held by
that country. Whether it is the economy, international diplomacy, or athletics, the impact of
China in the world seems to be a constant consideration. I have just returned from attending
the 24th Annual Great Wall meeting in Beijing. During the 4 days that I was in Beijing, the
abstract notion of growth and development was brought into the clear focus of reality.
My ﬁrst trip to China was in the mid-1980s, shortly after major interaction with the
United States and the Western world had been re-established. Needless to say, at that time
the country was largely undeveloped. Cars were few, bicycles ﬁlled the streets, housing had
not been upgraded, and clothing was utilitarian. Western fashions were rarely, if ever, seen.
Acupuncture and herbal medications were major factors in medicine. Although the potential
for growth and prosperity was obvious, at that time, China clearly was not at the same level
as the industrialized world.
I attended my ﬁrst Great Wall meeting 6 years ago. Organized by Professor Dayi Hu, the
scope, quality, and attendance of the meeting clearly reﬂected the enormous maturation of
cardiology in China. Dr. Hu had the foresight to recognize the great beneﬁt that a high-level
scientiﬁc and educational convention could provide for his country. He progressively grew
the meeting to include faculty from around the world who discussed leading-edge devel-
opments in cardiovascular medicine and surgery with thousands of Chinese physicians. As I
traveled about the city, the meeting clearly reﬂected the general development of the country.
Cars were more common, unfortunately resulting in trafﬁc congestion, high-rise buildings
were rising at a rapid pace, modern hotel chains had established a presence, and Western-
type fashions were more frequently in evidence. Preparations were underway to host the
Olympic Games. It was obvious that considerable growth and development was underway,
and that the country was well into its “adolescence.”
My experience in Beijing this year presented a different reality. The meeting again
included every aspect of modern cardiovascular medicine and surgery. However, the level of
the discussions and the sophistication of the question and answer sessions gave clear
evidence of the advanced state of cardiology in China. With rare exception (transcatheter
aortic valve replacement being perhaps the most obvious), the contemporary practice of
cardiology in China reﬂected that of the developed world. In fact, given the nature of
regionalization and the size of the population, patient volumes provided the opportunity for
Chinese cardiologists and surgeons to make some groundbreaking observations and answer
some pressing clinical questions.
I had the opportunity to visit Dr. Yu Jie Zhou and his colleagues at the Anzhen
Hospital, at which he is Vice President. This massive modern general hospital of about
1,200 beds receives patients from throughout the region and has clinical volumes that
stagger the imagination. I was told that 20,000 heart catheterizations and 10,000 percu-
taneous coronary interventions are performed at Anzhen every year. The interventional
JACC Vol. 62, No. 21, 2013 DeMaria
November 19/26, 2013:2024–5 Editor’s Page
2025procedures are performed in 13 state-of-the-art catheteri-
zation laboratories by a well-trained staff of over 80
cardiologists and serviced by a 150-bed intensive care unit.
Two interventional cases were underway simultaneously on
the Saturday afternoon of my visit. The number of open
heart surgeries is equally impressive, consisting of some
5,000 cases annually. Clearly, the case volumes at Anzhen
alone rival the enrollment of many multicenter international
trials. That this clinical material will be exploited for
research purposes was evidenced by a biobank of more than
12 freezers (60 freezers in the whole hospital) and a staff of
20 individuals acquiring and entering information about
phenotype and outcome into the appropriate database.
Space was available to double this capacity. This clinical
juggernaut was matched by a cardiovascular research center
funded with $20 million that contained the most modern
equipment available for basic investigation, including
sequencers. An animal facility (farm) has also been orga-
nized to study large animals. To call the clinical and
research operations at Anzhen “impressive” would qualify as
a gross understatement.
I am not sure how representative Anzhen Hospital is of all
medical facilities in China; in fact, they said that their case
volumes were one of the highest in the country. Neverthe-
less, it seemed obvious that there were a number of such
facilities throughout the country. Dr. Zhou and his staff
spoke matter-of-factly about their clinical experience, dis-
cussing cases and procedures on a level typical of what would
be encountered in the United States. It was obvious that the
state of clinical cardiology in China, at least in this setting,
had now reached adulthood, and that China has the energy
and determination to move into a leadership role in
cardiovascular medicine internationally.
An interesting aspect of my experience in Beijing was
the hunger of the junior faculty and cardiology fellows to
obtain information about and be educated in the process of
performing and publishing research. In fact, it was my role
of editor that triggered the invitation to lecture about how to
create high-quality manuscripts. These young cardiologists
(a surprisingly large number of whom were female) were
dedicated to devoting a large percentage of their effort and
career to investigation. My impression was that this interest
in research was a bit greater in China than what I have
witnessed in the United States, perhaps because the
opportunities for practice are not as great. This interest
existed despite the fact that the clinical demands were
overwhelming and that there was little or no opportunity for
discretionary time to devote to research. Although these
young cardiologists may be inexperienced in investigative
methods and manuscript preparation, their drive,enthusiasm, and quest for knowledge makes me conﬁdent
that they will be a major force in the research enterprise in
the near future.
The evolution in cardiology described above was mirrored
by the developments of the city in general. Beijing was ﬁlled
with new high-rise buildings, many of which were very
architecturally unique and attractive. I had a hard time
identifying areas of the city that had not been constructed in
the last 20 years. The streets were ﬁlled with late-model
automobiles similar to those that would be seen in the
United States. Even trafﬁc congestion was better than I had
remembered, perhaps due to a policy of alternating the use
of cars to certain days of the week. Clothes and accessories
were similar to those that you might expect in any large
American city, as were the cosmetics and hairstyles.
Restaurants serving “modern Chinese cuisine” offered an
ambiance that could have readily placed them in Manhattan.
I could easily have been in Hong Kong, Singapore, or even
San Francisco. The transition was nearly complete, the raw
potential of China had essentially become a reality, at least in
Beijing.
I am not sure exactly how one judges the societal and
medical maturation of a country. However, one observation,
or lack thereof, characterized the evolution for me. For the
ﬁrst time in several visits I no longer wondered at the
enormous changes that were taking place. It was just
taken for granted that the modern China was now a reality,
and that the elevated standards in daily life and medicine
were essentially to be taken for granted. Undoubtedly
there are many regions of the country where development
may lag behind Beijing’s, and in the country’s medical
research enterprise is just getting into gear. And, of course,
governmental and environmental issues exist that could not
be evaluated by me in my short visit. So, perhaps the country
would be best described as being in early adulthood.
However, the enormous clinical volume handled very
capably and the complementary research facilities to enable
important data to be derived from that experience, such as at
hospitals like Anzhen, exceeded that available in most
institutions in North America, Europe, and the rest of Asia.
The catching-up phase in China is largely complete, and one
can easily get a glimpse into what the future will hold.Address for correspondence to:
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